NIGMS Technology Development Programs (R21 and R01)

NIGMS Technology Development Programs (R21 and R01): The technology development R21 and R01 notices of funding opportunities (NOFOs) support technological innovations to advance biomedical research. Example technologies, which might originate from biomedical, engineering, or physical sciences disciplines, include instruments, devices, processes, algorithms, software, chemicals, biomolecules, or cells that have potential value for generating new basic biomedical research. The NOFOs support the earliest stages of technology development, establishing feasibility/proof of concept, and prototype validation, but do not support applications that address new biological questions. Investigators are strongly encouraged to contact program staff ( NIGMS_TechDev@nigms.nih.gov ) prior to and in preparation for submitting an application to these programs.

Technology Development R21

Technology Development R01

Parent R01

MIRA R35

Biomedical Technology Optimization & Dissemination RM1

Proof of Concept and Value
Exploratory Research / Technology Feasibility

Prototype Validation
Iterative Technology R&D / Validation Studies

Addressing Biological Questions
Applied Technology R&D and Dissemination

Late-Stage Technology Optimization for Broad Utility and Self-Sustaining Dissemination